Neurogene Inc Annual Shareholders Meeting Transcript
Good morning. I am Donna Cochener, General Counsel and Corporate Secretary of Neurogene Inc., which we will refer to as Neurogene in this meeting. Welcome to our 2026 Annual Meeting of the Stockholders. I would like to introduce Dr. Rachel McMinn, Founder, Chief Executive Officer, and Executive Chair of the Board of Directors, who will call the meeting to order.
Thank you, Donna, and good morning to you all. As the Chair of this Annual Meeting of Stockholders, I now call the meeting to order. With us here today are members of our Board of Directors and members of our senior management team.
Our Board of Directors are Dr. Cory Freedland, our Lead Independent Director; Dr. Robert Baffi; Ms. Christine Mikail; Dr. Sarah Noonberg; Mr. Rohan Palekar, Mr. Keith Woods, and myself. In addition, we have with us Leah Grant of Broadridge Financial Solutions Inc, Neurogene's proxy tabulator.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
